Search | IOVS | ARVO Journals

Showing 1 – 20 of 48

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract March 2012

Demonstration of Naturally Occurring Lacritin as an Antimicrobial Preservative in Topical Ophthalmic Preparations

Evan M. Berger; Sandeep S. Samudre; Alireza Hosseini; Patricia B. Williams; Frank A. Lattanzio, Jr.

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):1860. doi:

ARVO Annual Meeting Abstract March 2012

Effect of Cannabinoids and MethoxyPolyethylene Glycols on Rat Aqueous Flow Dynamics

Abhinav Reddy; Sandeep S. Samudre; Alireza Hosseini; Patricia B. Williams; Frank A. Lattanzio, Jr.

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):2487. doi:

ARVO Annual Meeting Abstract March 2012

Lacritin, a Novel Tear Glycoprotein, is an Effective Topical Antimicrobial Agent in an Animal Model

Alireza Hosseini; Frank A. Lattanzio, Jr.; Sandeep S. Samudre; John D. Sheppard, Jr.; Gordon W. Laurie; Robert L. McKown; Patricia B. Williams

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):6266. doi:

Physiology and Pharmacology August 2011

Lacritin, a Novel Human Tear Glycoprotein, Promotes Sustained Basal Tearing and Is Well Tolerated

PDF

Sandeep Samudre; Frank A. Lattanzio, Jr; Victoria Lossen; Alireza Hosseini; John D. Sheppard, Jr; Robert L. McKown; Gordon W. Laurie; Patricia B. Williams
TAGS: cyclosporine, glycoproteins, ocular lubricants, oryctolagus cuniculus, eye, fluid flow, intraocular pressure
Invest. Ophthalmol. Vis. Sci.. 2011; 52(9):6265-6270. doi: https://doi.org/10.1167/iovs.10-6220

ARVO Annual Meeting Abstract April 2011

Evaluation Of Anti-tubulin Agents For The Prevention Of Vasculopathy In A Rat Model Of Retinopathy Of Prematurity

Alireza Hosseini; Jorge L. Jacot; Frank A. Lattanzio, Jr.; Karl A. Schellenberg; Sandeep S. Samudre; Patricia B. Williams

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):3979. doi:

ARVO Annual Meeting Abstract April 2011

Cannabinoid Treatment Increases Choroidal Neovascularization in a Mouse Model of Exudative Age-Related Macular Degeneration

Elizabeth J. Crandall; Sandeep S. Samudre; Patricia B. Williams; Frank A. Lattanzio, Jr.

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):4015. doi:

ARVO Annual Meeting Abstract April 2011

Comparison Of Rat And Human Eyes For The Presence And Distribution Of Cb1 And Cb2 Receptors

Karl Rosen; Sandeep S. Samudre; Robert Mitchell; Patricia B. Williams; Frank A. Lattanzio, Jr.

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):4588. doi:

ARVO Annual Meeting Abstract April 2011

β-adrenergic Antagonists, Carbonic Anhydrase Inhibitors And α2-agonists Reduce The Effects Of Cannabinoids In A Rat Glaucoma Model

Kevin M. Bowman; Sandeep S. Samudre; Ben Mandel; Alireza Hosseini; Patricia B. Williams; Frank A. Lattanzio, Jr.

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):3101. doi:

ARVO Annual Meeting Abstract April 2011

Tear Break Up Time is Decreased in Ovariectomized Non-Human Primates

Patricia B. Williams; Sandeep S. Samudre; Mario C. Rodriguez; Dianne M. Duffy; Robert L. McKown; Gordon W. Laurie; Frank A. Lattanzio, Jr.

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):6701. doi:

ARVO Annual Meeting Abstract April 2010

The Terminal Regions of Lacritin May Contain Functional Domains That Increase Tear Flow

V. I. Lossen; S. Samudre; J. Sheppard, Jr.; R. L. McKown; G. W. Laurie; P. B. Williams; F. A. Lattanzio, Jr.

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):6279. doi:

ARVO Annual Meeting Abstract April 2010

OC-10X, a Novel Tubulin Inhibitor, Inhibits Neovasclarization in a Nonhuman Primate Model of AMD

P. B. Williams; F. A. Lattanzio, Jr.; C. M. Grevem; A. Hosseini; S. Samudre

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):2779. doi:

ARVO Annual Meeting Abstract April 2010

Comparison of the Pharmacokinetics of WIN 55212-2 and Latanoprost in the Human Cornea Versus the Human Sclera

E. A. Spencer; S. S. Samudre; F. A. Lattanzio, Jr.; P. B. Williams

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):3163. doi:

ARVO Annual Meeting Abstract April 2010

Topical Treatment With WIN55-212-2 and Free Radical Scavengers MPDTE and MPSEDE Reduced IOP and Preserved Retinal Status in Acute and Chronic Rat Ocular Models

F. A. Lattanzio, Jr.; K. A. Schellenberg; S. S. Samudre; A. Hosseini; P. B. Williams

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):3170. doi:

ARVO Annual Meeting Abstract April 2009

Loteprednol Etabonate Increases Glucocorticoid Receptor Migration in Pterygia

K. Rosen; S. Samudre; F. Lattanzio, Jr.; P. Williams; J. Sheppard, Jr.

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):2621. doi:

ARVO Annual Meeting Abstract April 2009

Expression of BFGF and IL-1 Alpha in Tears of Galactosemic Rats: Implications for Wound Healing and Neovascularization

M. Wertheimer; J. Helis; S. Hahto; J. D. Sheppard, Jr.; T. A. Jacot; F. A. Lattanzio, Jr.; P. B. Williams; J. L. Jacot

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):545. doi:

ARVO Annual Meeting Abstract April 2009

Inhibition of Choroidal Neovascularization Following Topical Administration of OC-10X Is Dose Dependent in the Rat Laser Model

A. Hosseini; F. A. Lattanzio, Jr.; S. S. Samudre; C. M. Greven; P. B. Williams

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):1170. doi:

ARVO Annual Meeting Abstract April 2009

Full-Field Electroretinogram Amplitude is Unaffected by Decreasing Dark Adaptation Time

G. DiSandro; S. S. Samudre; F. A. Lattanzio, Jr.; P. B. Williams

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):2169. doi:

ARVO Annual Meeting Abstract April 2009

Azithromycin Alters ProMMP-2 and TIMP-1 Following Corneal Wounding in an Experimental Animal Model of Diabetic Ocular Complications

J. L. Jacot; T. A. Jacot; S. Hahto; J. Helis; C. J. Sheppard; J. D. Sheppard, Jr.; F. A. Lattanzio, Jr.; P. B. Williams

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):2663. doi:

ARVO Annual Meeting Abstract April 2009

Absence of Adverse Effects Following 6 Months Topical Application of OC-10X

P. B. Williams; F. A. Lattanzio, Jr.; S. S. Samudre; A. Hosseini; C. M. Greven; J. L. Jacot

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):2974. doi:

ARVO Annual Meeting Abstract April 2009

Comparison of Multifocal Electroretinographic Analysis Techniques for Retinal Status Evaluation in a Rat Laser Age-Related Macular Degeneration Model

S. S. Samudre; F. A. Lattanzio, Jr.; A. Hosseini; P. B. Williams

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):3603. doi:

1 2 3

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Demonstration of Naturally Occurring Lacritin as an Antimicrobial Preservative in Topical Ophthalmic Preparations

Effect of Cannabinoids and MethoxyPolyethylene Glycols on Rat Aqueous Flow Dynamics

Lacritin, a Novel Tear Glycoprotein, is an Effective Topical Antimicrobial Agent in an Animal Model

Lacritin, a Novel Human Tear Glycoprotein, Promotes Sustained Basal Tearing and Is Well Tolerated

Evaluation Of Anti-tubulin Agents For The Prevention Of Vasculopathy In A Rat Model Of Retinopathy Of Prematurity

Cannabinoid Treatment Increases Choroidal Neovascularization in a Mouse Model of Exudative Age-Related Macular Degeneration

Comparison Of Rat And Human Eyes For The Presence And Distribution Of Cb1 And Cb2 Receptors

β-adrenergic Antagonists, Carbonic Anhydrase Inhibitors And α2-agonists Reduce The Effects Of Cannabinoids In A Rat Glaucoma Model

Tear Break Up Time is Decreased in Ovariectomized Non-Human Primates

The Terminal Regions of Lacritin May Contain Functional Domains That Increase Tear Flow

OC-10X, a Novel Tubulin Inhibitor, Inhibits Neovasclarization in a Nonhuman Primate Model of AMD

Comparison of the Pharmacokinetics of WIN 55212-2 and Latanoprost in the Human Cornea Versus the Human Sclera

Topical Treatment With WIN55-212-2 and Free Radical Scavengers MPDTE and MPSEDE Reduced IOP and Preserved Retinal Status in Acute and Chronic Rat Ocular Models

Loteprednol Etabonate Increases Glucocorticoid Receptor Migration in Pterygia

Expression of BFGF and IL-1 Alpha in Tears of Galactosemic Rats: Implications for Wound Healing and Neovascularization

Inhibition of Choroidal Neovascularization Following Topical Administration of OC-10X Is Dose Dependent in the Rat Laser Model

Full-Field Electroretinogram Amplitude is Unaffected by Decreasing Dark Adaptation Time

Azithromycin Alters ProMMP-2 and TIMP-1 Following Corneal Wounding in an Experimental Animal Model of Diabetic Ocular Complications

Absence of Adverse Effects Following 6 Months Topical Application of OC-10X

Comparison of Multifocal Electroretinographic Analysis Techniques for Retinal Status Evaluation in a Rat Laser Age-Related Macular Degeneration Model

To View More...

You must be signed into an individual account to use this feature.